OptiNose, Inc. (OPTN) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zevra Therapeutics, Inc.

XOMA Corp.

Alimera Sciences, Inc.

Applied Therapeutics, Inc.

Zomedica Corp.

OptiNose, Inc.

Atara Biotherapeutics, Inc.

Karyopharm Therapeutics, Inc.

Sagimet Biosciences, Inc.

PDS Biotechnology Corp.

Actinium Pharmaceuticals, Inc.

Why is OptiNose, Inc. ?

Flat results in Mar 25

INVENTORY TURNOVER RATIO(HY) Lowest at 0.74%
EPS(Q) Lowest at USD -1.92 MM

Risky - Not traded in last 10 days

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 0%, its profits have risen by 14.2%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals: Major)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is OptiNose, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

OptiNose, Inc.

-44.83%

-0.49

91.34%

S&P 500

13.22%

0.61

20.23%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

17.07%

EBIT Growth (5y)

12.88%

EBIT to Interest (avg)

-2.88

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.90

Sales to Capital Employed (avg)

1.26

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

86.63%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-1.57

EV to EBIT

-9.60

EV to EBITDA

-9.77

EV to Capital Employed

-25.70

EV to Sales

1.86

PEG Ratio

Dividend Yield

93.75%

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET PROFIT(HY)

Higher at USD -12.22 MM

RAW MATERIAL COST(Y)

Fallen by 1.08% (YoY

-2What is not working for the Company

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.74%

EPS(Q)

Lowest at USD -1.92

Here's what is working for OptiNose, Inc.

Net Profit

Higher at USD -12.22 MM

than preceding 12 month period ended Mar 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Raw Material Cost

Fallen by 1.08% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for OptiNose, Inc.

EPS

Lowest at USD -1.92

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Inventory Turnover Ratio

Lowest at 0.74%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio